SEC Tracker
Get the app

Pacira BioSciences PCRX

Shawn Cross (CFO) withheld for taxes 9,540 PCRX at $36.39, worth $347K

Form
4
Filed
Importance
Routine
  1. Net shares owned after transaction: 95,801
  2. Transaction date: Oct 30, 2026

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Pacira BioSciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Phibro Animal Health PAHC public float $764M, Dec 31, 2025
  2. uniQure QURE public float $765M, Jun 30, 2025
  3. Cogent Biosciences COGT public float $773M, Jun 30, 2025
  4. Immunome IMNM public float $729M, Jun 30, 2025
  5. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025